These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 8847814)

  • 41. Glucocerebrosidase gene mutations in patients with type 2 Gaucher disease.
    Stone DL; Tayebi N; Orvisky E; Stubblefield B; Madike V; Sidransky E
    Hum Mutat; 2000; 15(2):181-8. PubMed ID: 10649495
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical, genetic, and brain sonographic features related to Parkinson's disease in Gaucher disease.
    Böttcher T; Rolfs A; Meyer B; Grossmann A; Berg D; Kropp P; Benecke R; Walter U
    J Neurol; 2013 Oct; 260(10):2523-31. PubMed ID: 23811968
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical and molecular aspects of Gaucher disease in New Zealand.
    Woodfield MJ; Woodfield DG; Winship IM
    N Z Med J; 1997 Aug; 110(1050):316-9. PubMed ID: 9315031
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [An analysis of mutations causing Gaucher disease in Chinese population].
    Zhang WM; Tang NL; Meng Y; Yao FX; Qiu ZQ; Duan YL; Huang SZ; Shi HP
    Zhonghua Yi Xue Za Zhi; 2009 Dec; 89(48):3397-400. PubMed ID: 20223112
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Phenotypic and genotypic heterogeneity in Gaucher disease type 1: a comparison between Brazil and the rest of the world.
    Sobreira E; Pires RF; Cizmarik M; Grabowski GA
    Mol Genet Metab; 2007 Jan; 90(1):81-6. PubMed ID: 16996765
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Three Gaucher-disease-producing mutations in a patient with Gaucher disease: mechanism and diagnostic implications.
    Beutler E; Liebman H; Gelbart T; Stefanski E
    Acta Haematol; 2000; 104(2-3):103-5. PubMed ID: 11154983
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [The molecular genetic diagnostic of Gaucher disease type I].
    Lukina KA; Fevrayeva IS; Sysoyeva EP; Sudarikov AB; Lukina EA
    Klin Lab Diagn; 2014 Jan; (1):53-5. PubMed ID: 25069222
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Gaucher disease among Chinese patients: review on genotype/phenotype correlation from 29 patients and identification of novel and rare alleles.
    Choy FY; Zhang W; Shi HP; Zay A; Campbell T; Tang N; Ferreira P
    Blood Cells Mol Dis; 2007; 38(3):287-93. PubMed ID: 17196853
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Characterization of glucocerebrosidase in Greek Gaucher disease patients: mutation analysis and biochemical studies.
    Michelakakis H; Dimitriou E; Van Weely S; Boot RG; Mavridou I; Verhoek M; Aerts JM
    J Inherit Metab Dis; 1995; 18(5):609-15. PubMed ID: 8598642
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Enzyme replacement therapy for Gaucher disease in Australia.
    Goldblatt J; Szer J; Fletcher JM; McGill J; Rowell JA; Wilson M
    Intern Med J; 2005 Mar; 35(3):156-61. PubMed ID: 15737135
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Gaucher disease: studies of phenotype, molecular diagnosis and treatment.
    Rice EO; Mifflin TE; Sakallah S; Lee RE; Sansieri CA; Barranger JA
    Clin Genet; 1996 Mar; 49(3):111-8. PubMed ID: 8737974
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Retroviral-mediated transfer of the human glucocerebrosidase gene into cultured Gaucher bone marrow.
    Nolta JA; Yu XJ; Bahner I; Kohn DB
    J Clin Invest; 1992 Aug; 90(2):342-8. PubMed ID: 1379609
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [French results of enzyme replacement therapy in Gaucher's disease].
    Schaison G; Caubel I; Belmatoug N; Billette de Villemeur T; Saudubray JM
    Bull Acad Natl Med; 2002; 186(5):851-61; discussion 861-3. PubMed ID: 12412377
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Gaucher's disease: current aspects].
    Klein M; Kaminsky P; Duc M
    Rev Med Interne; 1995; 16(6):447-56. PubMed ID: 7652229
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Gaucher disease: pediatric concerns.
    Elstein D; Abrahamov A; Dweck A; Hadas-Halpern I; Zimran A
    Paediatr Drugs; 2002; 4(7):417-26. PubMed ID: 12083970
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ambroxol improves lysosomal biochemistry in glucocerebrosidase mutation-linked Parkinson disease cells.
    McNeill A; Magalhaes J; Shen C; Chau KY; Hughes D; Mehta A; Foltynie T; Cooper JM; Abramov AY; Gegg M; Schapira AH
    Brain; 2014 May; 137(Pt 5):1481-95. PubMed ID: 24574503
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Analysis and classification of 304 mutant alleles in patients with type 1 and type 3 Gaucher disease.
    Koprivica V; Stone DL; Park JK; Callahan M; Frisch A; Cohen IJ; Tayebi N; Sidransky E
    Am J Hum Genet; 2000 Jun; 66(6):1777-86. PubMed ID: 10796875
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Understanding patient and parent/caregiver perceptions on gene therapy in Gaucher disease: an international survey.
    Collin-Histed T; Rosenberg A; Hopman N; Pacey J
    Orphanet J Rare Dis; 2023 Jan; 18(1):5. PubMed ID: 36611195
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Prenatal diagnosis of Gaucher disease].
    Germain DP; Benistan K
    Rev Med Interne; 2007 Oct; 28 Suppl 2():S193-7. PubMed ID: 18240370
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Gaucher disease: the origins of the Ashkenazi Jewish N370S and 84GG acid beta-glucosidase mutations.
    Diaz GA; Gelb BD; Risch N; Nygaard TG; Frisch A; Cohen IJ; Miranda CS; Amaral O; Maire I; Poenaru L; Caillaud C; Weizberg M; Mistry P; Desnick RJ
    Am J Hum Genet; 2000 Jun; 66(6):1821-32. PubMed ID: 10777718
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.